GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AC Immune SA (NAS:ACIU) » Definitions » Institutional Ownership

AC Immune (AC Immune) Institutional Ownership : 3.42% (As of Jun. 08, 2024)


View and export this data going back to 2016. Start your Free Trial

What is AC Immune Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, AC Immune's institutional ownership is 3.42%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, AC Immune's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, AC Immune's Float Percentage Of Total Shares Outstanding is 53.57%.

AC Immune Institutional Ownership Historical Data

The historical data trend for AC Immune's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AC Immune Institutional Ownership Chart

AC Immune Historical Data

The historical data trend for AC Immune can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 1.34 1.26 1.26 1.20 3.51 3.53 3.53 3.46 3.43 3.42

AC Immune Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

AC Immune (AC Immune) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AC Immune SA (NAS:ACIU) » Definitions » Institutional Ownership
Comparable Companies
CELC CMPX NUVB XERS YMAB DRTS ARQT ZURA EPIX HUMA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
IMR:Germany IMR:Germany
Address
EPFL Innovation Park, Building B, Lausanne, CHE, 1015
Website
https://www.acimmune.com
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.